Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

Background: A recent phase II trial reported prolonged survival in patients with advanced biliary tract cancer (BTC) following treatment with nab-paclitaxel plus gemcitabine-cisplatin (Gem/Cis/nab-P). We aimed to evaluate the clinical outcomes of Gem/Cis/nab-P in Asian patients with advanced BTC in...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Jaekyung Cheon, Choong-kun Lee, Yun Beom Sang, Hye Jin Choi, Min Hwan Kim, Jun Ho Ji, Kwang Hyun Ko, Chang-Il Kwon, Dae Jung Kim, Sung Hoon Choi, Chan Kim, Beodeul Kang, Hong Jae Chon
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	SAGE Publishing 2021-08-01
Serie:	Therapeutic Advances in Medical Oncology
Accesso online:	https://doi.org/10.1177/17588359211035983
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!